Optimization of the medical diagnostics and therapy managing in colorectal tumors using F-18-Deoxyglucose (FDG) positron emission tomography (PET) and gene expression data (GenPET Colon-2008).
- Conditions
- C18.0-C18.9
- Registration Number
- DRKS00000329
- Lead Sponsor
- Deutsches Krebsforschungszentrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients with a histologically confirmed primary colorectal carcinoma
Exclusion Criteria
rejection of the examination by the patient
diabetes mellitus
acute psychosis and other diseases with limited possibilities to understand the examination
pregnant women
claustrophobic patients
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method recurrent free survival
- Secondary Outcome Measures
Name Time Method individual survival